Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
06/1998
06/23/1998US5770423 Nucleic acids encoding cdc25 A and cdc25 B proteins and method of making cdc25 A and cdc25 B proteins
06/23/1998US5770421 Human ALK protein tyrosine kinase
06/23/1998US5770418 Purified polyporus laccases and nucleic acids encoding same
06/23/1998US5770415 Peptidoglycan biosynthetic gene mur a from Strepococcus pneumoniae
06/23/1998US5770414 Regulatable retrovirus system for genetic modification of cells
06/23/1998US5770413 Expression of phytase in plants
06/23/1998US5770408 Method for the amplification of a base sequence
06/23/1998US5770406 Enzyme with β-(1-6)-endoglucanase activity
06/23/1998US5770405 From xanthomonas; 100 fold greater specificity for n-acetylglucosamine than for n-acetylgalactosamine
06/23/1998US5770403 Genetically engineered nucleic acid coding for antibodies which bind to and block interleukins
06/23/1998US5770402 DNA encoding macrophage inflammatory protein-1γ
06/23/1998US5770400 Exogenous gene expression vector containing chick β-actin gene promoter
06/23/1998US5770398 Vector for integration site independent gene expression in mammalian host cells
06/23/1998US5770397 Method of using eukaryotic expression vectors comprising the BK virus enhancer
06/23/1998US5770396 Isolation characterization, and use of the human beta subunit of the high affinity receptor for immunoglobulin E
06/23/1998US5770386 Methods and compositions for increasing the sensitivity of a cell to a DNA damaging agent
06/23/1998US5770384 Method for determining compound interaction with E2 binding proteins
06/23/1998US5770377 Detecting and preventing deactivation of tumor suppressors or anticarcinogenic agents
06/23/1998US5770375 Dna probe
06/23/1998US5770374 Methods for identifying oncogenes and anti-oncogenes
06/23/1998US5770373 Rapid and sensitive detection of antibiotic-resistant mycobacteria using oligonucleotide probe specific for ribosomal RNA precursors
06/23/1998US5770371 Modification of cryptic splice sites in heterologous genes expressed in fungi
06/23/1998US5770370 Nuclease protection assays
06/23/1998US5770369 Nucleic acid mediated electron transfer
06/23/1998US5770368 Cryptosporidium detection method
06/23/1998US5770367 Tag reagent and assay method
06/23/1998US5770366 Melanoma-inhibiting protein
06/23/1998US5770365 Exposing double stranded nucleic acid (also having a single stranded region) bound to solid support to mixture of target single stranded nucleic acid and binding ligand to promote hybridization
06/23/1998US5770361 Protein conferring an inducible resistance to glycopeptides, particularly in gram-positive bacteria
06/23/1998US5770360 Elimination of false negatives in nucleic acid detection
06/23/1998US5770359 Encodes the complete amino acid sequence of a mammalian glutamine synthetase
06/23/1998US5770358 Tagged synthetic oligomer libraries
06/23/1998US5770356 Phagemids coexpressing a surface receptor and a surface heterologous protein
06/23/1998US5770213 Endotoxin-free; otitis media, sinusitis, meningitis, and chronic pulmonary obstructive disease
06/23/1998US5770212 Recombinant poxviruses with foreign DNA in essential regions
06/23/1998US5770211 Recombinant raccoon pox viruses and their use as an effective vaccine against feline infectious peritonitis virus disease
06/23/1998US5770210 Expression of htlv-iii envelope proteins by recombinant dna methods, aids vaccine
06/23/1998US5770209 Acceleration of wound healing using connective tissue growth factor
06/23/1998US5770208 Staphylococcus aureus B-linked hexosamine antigen
06/23/1998US5770203 Modified cholera toxin based on mutagenized subunit A
06/23/1998US5770202 Cloning and sequencing of allergens of dermatophagoides (house dust mite)
06/23/1998US5770198 Anticoagulants
06/23/1998US5770197 Methods for regulating the immune response using B7 binding molecules and IL4-binding molecules
06/23/1998US5770196 Modified antibody variable domains and therapeutic uses thereof
06/23/1998US5770195 Antitumor
06/23/1998US5770192 Recombinant nuclear polyhedrosis virus, insecticide toxin
06/23/1998US5770157 Methods and apparatus for the generation of chemical libraries
06/23/1998US5770104 Detergent compositions containing substantially pure EG III cellulase
06/23/1998CA2222823A1 Composition of slap-130, a slp-76 associated protein and methods of use therefor
06/23/1998CA1339923C Electric field mediated dna transformation of plant cells and organelles
06/21/1998CA2218440A1 Method of analysis using signal amplification
06/21/1998CA2218439A1 Method of identifying a nucleic acid using triple helix formation of adjacently annealed probes
06/20/1998CA2217698A1 Anti-obesity proteins
06/19/1998CA2223076A1 Isolation and characterization of a gene encoding a low molecular weight glutenin
06/18/1998WO1998026097A2 NUCLEIC ACID PRIMERS AND PROBES FOR DETECTING $i(LEGIONELLA PNEUMOPHILA)
06/18/1998WO1998026096A1 Method for rapid gap closure
06/18/1998WO1998026095A1 Releasable nonvolatile mass-label molecules
06/18/1998WO1998026094A1 Reading frame independent epitope tagging
06/18/1998WO1998026092A1 Atherothrombotic disorders: mutation in the factor xiii gene
06/18/1998WO1998026088A1 Bacillus strain and antibiotic screening method
06/18/1998WO1998026087A1 Bacillus strain and antibiotic screening method
06/18/1998WO1998026084A1 Expression of active interferon beta 1 using recombinant rna replicons
06/18/1998WO1998026083A1 Antifungal polypeptide and methods for controlling plant pathogenic fungi
06/18/1998WO1998026082A1 Methods of using the nim1 gene to confer disease resistance in plants
06/18/1998WO1998026081A1 Transgenic plants having increased freezing and choline tolerance
06/18/1998WO1998026080A1 Method for expression of heterologous proteins in yeast
06/18/1998WO1998026079A1 Methods for modulating metabolic pathways of micro-organisms and micro-organisms obtainable by said methods
06/18/1998WO1998026078A1 H mutant alpha-amylase enzymes
06/18/1998WO1998026077A1 USE OF A VECTOR EXPRESSING DNA POLYMERASE β AS MEDICINE
06/18/1998WO1998026076A1 Novel human carbonyl reductase
06/18/1998WO1998026075A1 Non-m non-o hiv strains, fragments and applications
06/18/1998WO1998026074A1 Fusion protein comprising the whole or part of the pp65 protein of human cmv, useable in particular for preparing a vaccine
06/18/1998WO1998026073A1 Strain belonging to the genus bacillus and insecticidal proteins
06/18/1998WO1998026072A1 Streptococcus pneumoniae dna sequences
06/18/1998WO1998026071A1 Human cc chemokine elc
06/18/1998WO1998026070A1 Bone stimulating factor
06/18/1998WO1998026069A1 Methods and compositions for identifying morphogen analogs
06/18/1998WO1998026068A1 Human apoptosis-related calcium-binding protein
06/18/1998WO1998026067A1 Adipocyte-specific differentiation-related protein
06/18/1998WO1998026066A1 Expression of proteins for treating asthma via ligand mediated activation of their encoding genes
06/18/1998WO1998026065A1 Mammalian icyp (iodocyanopindolol) receptor and its applications
06/18/1998WO1998026064A2 Method for altering the nutritional content of plant seed
06/18/1998WO1998026063A1 Nur-re a response element which binds nur nuclear receptors and method of use therefor
06/18/1998WO1998026062A2 Synthetic antisense oligodeoxynucleotides and pharmaceutical compositions containing them
06/18/1998WO1998026061A2 Expression vectors containing accessory molecule ligand genes and their use for immunomodulation and treatment of malignancies and autoimmune disease
06/18/1998WO1998026060A2 Materials and methods for gene transfer
06/18/1998WO1998026057A1 Reduction of phosphorus containing components in edible oils comprising a high amount of non-hydratable phosphorus by use of a phospholipase, a phospholipase from a filamentous fungus having phospholipase a and/or b activity
06/18/1998WO1998026056A1 Protein phosphatase regulatory subunit
06/18/1998WO1998026054A2 Pyk2 related products and methods
06/18/1998WO1998026053A1 NOVEL β1→4 N-ACETYLGLUCOSAMINYLTRANSFERASE AND GENE ENCODING THE SAME
06/18/1998WO1998026052A1 Tryparedoxin peroxidase
06/18/1998WO1998026051A2 Tryparedoxin, expression plasmid, process of production, use, test system and pharmaceutical preparation
06/18/1998WO1998026050A2 Glutathionylspermidine synthetase
06/18/1998WO1998026049A1 Recombinant equine herpesvirus type 1 (ehv-1) comprising a dysfunctional gene 71 region and use thereof as a vaccine
06/18/1998WO1998026047A1 Methods and compositions for identifying morphogen analogs
06/18/1998WO1998026046A2 A novel transcription factor expressed in cycling cells, nucleic acid molecules encoding said transcription factor and its promoter region and uses thereof
06/18/1998WO1998026042A1 Induced chromosomal deletion
06/18/1998WO1998025971A1 Monovalent antibody fragments
06/18/1998WO1998025967A1 Hvem polypeptides and uses thereof
06/18/1998WO1998025963A1 Analysis and separation of platelet-derived growth factor proteins
1 ... 3518 3519 3520 3521 3522 3523 3524 3525 3526 3527 3528 3529 3530 3531 3532 3533 3534 3535 3536 3537 3538 ... 4023